Sui et al. derived nuclear transfer embryonic stem cells (SCNT) from T1D patients which resembled iPSCs in morphology and function and differentiated them to generate insulin-producing beta-cells that were capable of regulating glucose levels when transplanted in mice lacking endogenous beta-cells. Here, INS is linked to type 1 diabetes mellitus.